Health & Medicine Week articles from April 2004

Health & Medicine Week archives from April 2004

Medical privacy law makes health research harder, more expensive.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- As the 1-year anniversary of the U.S. medical privacy law approaches, a new study shows the negative impact that its implementation may be having on certain kinds of health research. At the Annual...

Healthier milk straight from the cow.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- British scientists have found a natural way to produce healthier milk and butter. Cows fed rapeseed oil as part of their daily diet produce milk with a significantly less saturated fat. Butter made...

Deficits associated with prenatal alcohol exposure can be seen as early as infancy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Alcohol-exposed babies respond more slowly to their environment, and take longer to calm down, according to a new study. Most of the research on arousal and attention deficits caused by prenatal...

One million disabled adults lack adequate help with essential needs.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- About 3.3 million adults living in the community need assistance from another person in two or more activities of daily living essential for their survival, and nearly a million of those individuals...

Researchers discover memory mechanism.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Massachusetts Institute of Technology (MIT) neuroscientists have discovered a new brain mechanism controlling the formation of lasting memories. This mechanism explains how signals between neurons...

Impaired sense of smell increases risk for certain hazards.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Patients with an impaired or absent sense of smell are at risk for experiencing certain hazards that may have been avoided with an intact sense of smell, according to a new study. Approximately 2.7...

FDA clears LaparoShield system for minimally invasive abdominal surgery.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pall Corporation (PLL) announced U.S. Food and Drug Administration (FDA) clearance to market its new LaparoShield Conditioned Insufflation Gas (CIG) System. By conditioning the carbon dioxide...

New study demonstrates the benefits of intensive statin therapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Results from a new study demonstrate the benefit of initiating intensive cholesterol-lowering therapy within 10 days in people hospitalized with an acute coronary syndrome. The TIMI 22 study...

Women with acute coronary syndrome receive less treatment than men, data shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- According to an analysis of more than 35,000 patients, women entering a hospital with acute coronary syndrome (ACS) were less likely than men to receive many medications that have been shown to improve...

Lovenox effective in non-ST-elevation acute coronary syndromes, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a landmark, 10,027-patient study show that Lovenox (enoxaparin sodium injection) is as effective as unfractionated heparin (UFH) in the treatment of high-risk patients with...

Cloretazine receives Fast Track designation from FDA.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vion Pharmaceuticals, Inc., (VION) has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Cloretazine (VNP40101M) in relapsed or refractory acute myeloid leukemia...

Endoglin is highly expressed in eyes with choroidal neovascularization.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Endoglin is highly expressed in eyes with choroidal neovascularization. "Endoglin (CD105) is a membrane protein involved in the transforming growth factor (TGF)-beta receptor signaling pathway with...

Positive results announced for long-term study of Zeatin.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Senetek PLC (SNTK) announced uniformly positive results for its multi-faceted study of the effects of its patented adenine derivative Zeatin on human skin cells. The study, conducted at the...

Manufacture of validation batches for allergy drug completed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Elite Pharmaceuticals, Inc., (ELI) announced completion of the manufacture of validation batches for a once-a-day product that treats allergies and the symptoms of allergies. The product was...

Test kit launched to check for residential indoor allergens.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- American Home Laboratories, Inc., (AHL) announced the launch of AllergenREPORT, a home test kit that screens for elevated levels of residential indoor allergens, including dust mite, cockroach, cat, and...

Hay fever hits New Mexico hard.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- New Mexico's hay fever season has arrived with a vengeance. "The junipers are going now," said Curtis Smith, a horticulture specialist with New Mexico State University. "They started a few weeks...

Alternaria stimulates a case of life-threatening asthma.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Alternaria stimulates a case of life-threatening asthma. "Acute, severe asthma attacks can be precipitated by a variety of stimuli including exposure to aeroallergens, viral respiratory infections,...

Clearant process-treated allografts reduce risk of infection, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Clinical findings presented at the annual meeting of the American Association of Orthopedic Surgeons showed that patients who received human tissue allograft implants that were treated with a new...

Chondroitin sulfate of appican interacts with neuroregulatory factors.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors. "Appican produced by rat C6...

Selective BACE-1 inhibitors synthesized.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Scientists have synthesized a series of selective beta-site amyloid precursor protein cleaving enzyme (BACE-1) inhibitors. According to a study from the United States, "An effective approach for...

Synaptic frailty and vesicle trafficking in Alzheimer disease reviewed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers review synaptic frailty and clathrin-mediated synaptic vesicle trafficking in Alzheimer disease in a recent issue of Trends in Neurosciences. "Loss of synapses contributes to the...

LDL receptor-related protein overexpression linked to memory deficits.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amyloid model mice overexpressing the low-density lipoprotein receptor-related protein exhibit increased soluble amyloid-beta peptide and memory deficits. "Amyloid-beta peptide (A-beta) is central...

Microglial activation facilitates A-beta plaque removal.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Microglial activation facilitates A-beta plaque removal following intracranial anti-A beta antibody administration. According to a study from the United States, "The mechanisms by which anti-A-beta...

Drug shows promise against Lou Gehrig disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig disease, causes nerve cells in the spinal cord and brain to die, eventually leading to paralysis and death. In the April 2004 issue of...

Researchers find that coronary aneurysms are independent predictor of mortality.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a study presented at the American College of Cardiology's 53rd Scientific Sessions in New Orleans concludes that coronary aneurysms - regardless of size - are associated with a increased...

Oral formulation of Fasudil improves stable angina in study patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SHR) announced that study patients with stable angina receiving the oral formulation of fasudil showed an improvement in oxygen delivery to the heart. Fasudil, which Schering...

Veins of the human female gynecological system behave like a venous pool.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Veins of the human female gynecological system behave like a venous pool. "We described the anatomy of the utero-ovarian venous system in the adult postmenopausal female cadaver using casts and the...

ABthrax found to be safe and well tolerated.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced that the results of a phase I clinical trial demonstrate that ABthrax (human monoclonal antibody to Bacillus anthracis protective antigen) is safe and well...

Company announces new biodefense-related contract work.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Commonwealth Biotechnologies, Inc., (CBTE) (CBI), a life sciences contract research organization and biotechnology company, announced execution of two major biodefense-related contracts valued at nearly...

GyrB distinguishes members of Bacillus anthracis-cereus-thuringiensis group.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The gyrB gene can be used to distinguish members of the Bacillus anthracis-cereus-thuringiensis group. "Bacillus anthracis, the causative agent of the human disease anthrax, Bacillus cereus, a...

U.S. to stockpile new vaccine.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The U.S. government is planning to stockpile enough doses of an experimental new anthrax vaccine to inoculate 25 million people. Studies designed to prove whether this new vaccine is safe are still...

Antibiotics alter the normal bacterial flora in humans.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Bacteria that are resistant to antibiotics can live in the human intestines for at least 1 year. Professor Charlotta Edlund from the Karolinska Institute in Stockholm, Sweden, and Research Professor...

Consumer group seeking ban on antidepressant sues U.S. government.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A consumer advocacy group sued the United States government March 15, 2004, seeking to force a ban on sales of the antidepressant Serzone. The drug can cause deadly liver failure and is linked to 20...

Camels may be vector for multiresistant Salmonella.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Camels could be a vector for multiresistant strains of Salmonella. In a recent study, a "total of 714 samples consisting of feces, mesenteric lymph nodes, liver, spleen, abdominal and diaphragmatic...

Antioxidant gene therapy protects hearing against antibiotic-mediated injury.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Antioxidant gene therapy protects hearing against antibiotic-mediated injury. According to a study from the United States, "aminoglycosides are commonly used antibiotics that often induce...

A 2'-succinyl linker provides oligonucleotides new conduits for conjugation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A 2'-succinyl linker provides oligonucleotides new conduits for conjugation. According to a study from Austria, "conjugation of ligands to antisense oligonucleotides is a promising approach for...

Pluronic lends a hand to cationic liposomes bearing antisense oligonucleotides.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pluronic lends a hand to cationic liposomes bearing antisense oligonucleotides. According to a study from the Peoples Republic of China, "cationic liposomes modified by different Pluronic block...

Green fluorescent protein causes mitochondria to aggregate with Bcl-2.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Green fluorescent protein causes mitochondria to aggregate in the presence of the Bcl-2 family proteins. "Green fluorescent protein (GFP) has been widely used in a variety of experiments in cell...

Early survival with the total artificial heart shows recent improvement.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Reduced infections and improved survival with the total artificial heart result from better patient management, researchers say. According to a study from Canada, "We report our experience with the...

Cleavage of precursor enzyme causes amylase secretion by Aspergillus.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers have found evidence that cleavage of the precursor enzyme by autocatalysis caused secretion of multiple amylases by Aspergillus niger. "The observation that a mutant strain of...

Foradil Certihaler receives first European approval.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- SkyePharma PLC (SKYE, SKP) announced that the Swiss pharmaceutical regulatory authority has approved Foradil Certihaler (formoterol fumarate inhalation powder). Foradil Certihaler was codeveloped by...

Hartford ranked 10th worst city in the U.S. for asthma patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new report says Hartford, Connecticut, is the 10th worst metropolitan area in the United States for asthmatics. The nonprofit group Asthma and Allergy Foundation of America report is based on...

Kos announces strategic acquisition of Azmacort franchise.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Kos Pharmaceuticals, Inc., (KOSP) has entered into a product acquisition agreement with Aventis Pharmaceuticals Holdings, Inc., and a supply agreement with Aventis Pharmaceuticals, Inc., to acquire...

Study: Inhaled steroid therapy does not reduce fetal growth.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Inhaled steroid therapy by pregnant women with asthma does not lead to a restriction in fetal growth, according to a new study. In the largest sample to date examining the potential effects that...

Company reports that interleukin-1 gene variants increase risk for early CHD.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Interleukin Genetics, Inc., (ILGN) reported at the American College of Cardiology meeting that pro-inflammatory variants of the interleukin-1 (IL-1) gene cluster are associated with increased risk for...

LSBC enters research phase for development of atherosclerosis therapeutic.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Large Scale Biology Corp.'s (LSBC) exclusive license agreement with Cincinnati (Ohio) Children's Hospital Medical Center for the development of a drug to treat a leading cause of death in the U.S. has...

Medical device company announces launch of Eagle Eye IVUS imaging catheter.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Volcano Therapeutics, Inc., announced the global launch of its Eagle Eye intravascular ultrasound (IVUS) imaging catheter at the American College of Cardiology 53rd Scientific Session. The Eagle...

PhotoPoint PDT may stabilize atherosclerotic vulnerable plaque.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (MRVT), a pharmaceutical development company specializing in PhotoPoint photodynamic therapy (PDT), announced preclinical data that may support the future treatment of...

Study to examine obesity-associated diabetes and heart disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The rise in obesity, now at epidemic levels in the United States, has been matched by a rise in diabetes, a deadly combination that increases heart disease risk by two to five times. Research has...

Study demonstrates Metadate CD has greater effect than Concerta.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A study published in the March 2004 online issue of Pediatrics comparing the effects of two extended-release methylphenidate formulations in children with attention deficit hyperactivity disorder (ADHD)...

Public health monitoring of autism spectrum disorders is ongoing.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Public health monitoring of autism spectrum disorders is ongoing. According to researchers in the United States "Developmental disabilities (DDs) are conditions characterized by physical, cognitive,...

CDC removes Hong Kong from bird ban.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The U.S. Centers for Disease Control and Prevention (CDC) has removed Hong Kong from the jurisdictions included in an importation ban on birds and bird products. The decision to remove Hong Kong is...

Chinese delegation visits Delaware to discuss avian influenza.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Delaware officials met March 16, 2004, with a delegation from the Chinese embassy to explain what the state has done to control an avian flu outbreak and request that China lift an import ban on...

Cardiology systems provider receives growth strategy excellence award.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Quinton Cardiology Systems has received Frost & Sullivan's Growth Strategy Excellence Award in the global cardiovascular monitoring devices market. According to Frost & Sullivan, the Growth Strategy...

Bacteria manipulate Rho to enhance their survival.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Bacteria manipulate Rho to enhance their survival. According to a study from the United States, "Many features of cell behavior are regulated by Rho family GTPases, but the most profound effects of...

Company helps hospitals, manufacturers respond to new FDA rules.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC), a pharmaceutical services company, said it has the broadest array of solutions to help pharmaceutical manufacturers and hospitals respond to the U.S. Food and Drug...

Milestone payments received, first patients treated with Prolieve.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Celsion Corp. (CLN) announced that it has fulfilled the milestone obligations included in its distribution agreement with Boston Scientific Corporation, under which Boston Scientific will market...

$5.9M contract awarded for development of biowarfare technology.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX, ACTG) announced that its CombiMatrix Group has received a 2-year contract from the U.S. Department of Defense (DOD) that will provide $5.9 million to further the...

Biosensor rapidly identifies broad-range of infectious organisms.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- RoboDesign International, Inc., has entered into an agreement with Isis Pharmaceuticals' Ibis program to design, develop, and manufacture commercial-ready, self-contained systems for the identification...

Student builds micro biosensor chip to move DNA molecules.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A Johns Hopkins undergraduate has constructed a new type of microchip that can move and isolate DNA and protein molecules. He believes that by linking the chip with analysis equipment, a user could...

Vitamins reduce risk for congenital anomalies other than neural tube defects.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vitamin supplements reduce the risk for congenital anomalies other than neural tube defects. "Randomized trials, supported by many observational studies, have shown that periconceptional use of...

Drinking well water is associated with bladder cancer in Argentina.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Study finds that the incidence of bladder cancer associated with arsenic in drinking water is lower than thought, but intake of well water long before the study was associated with an increased...

Tumor suppressor genes predict bladder cancer future.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The presence of two mutated genes in bladder cancer tumors indicates there is a high risk that the cancer will continue grow and spread, says a Baylor College of Medicine (BCM) researcher in a new...

Optical glucose sensor holds promise for diabetics and intensive care patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers at the University of California, Santa Cruz (UCSC), have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and...

Positive phase Ib/II clinical trial results reported for Hemospan.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Sangart, Inc., announced positive results from its phase Ib/II clinical trial involving Hemospan (MP4), a hemoglobin-based oxygen carrier designed to serve as an alternative for blood transfusions. ...

Skeletal imaging agent approved by FDA.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Draximage, Inc., the radiopharmaceutical subsidiary of Draxis Health, Inc., (DRAX) (DAX), has received approval from the U.S. Food and Drug Administration (FDA) to produce and market a new formulation...

Allomatrix Injectable Putty receives FDA clearance.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Wright Medical Group, Inc., (WMGI) announced receipt of marketing clearance from the U.S. Food and Drug Administration (FDA) for its Allomatrix Injectable Putty containing demineralized bone matrix. ...

Britain restricts blood donations as a precaution against mad cow's disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The British government said March 16, 2004, it would ban blood donations from people who had received transfusions since 1980, as a precaution against transferring the human form of mad cow's disease....

Funding pending for Canadian cattle industry reeling from mad cow scare.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Canada's federal budget will include an immediate cash injection of more than $500 million (US$375 million) to help the cattle industry survive until exports to the United States resume, the Globe and...

U.S. expands mad cow testing to cover 221,000 animals.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The U.S. Agriculture Department will expand its testing for mad cow disease after the single U.S. case in December to more than 221,000 animals, 10 times the number tested last year, officials say. ...

Hudson licenses radiosensitizer IPdR.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hudson Health Sciences, Inc., (HHS), a biopharmaceutical company headquartered in San Francisco, California, has licensed IPdR, a radiosensitizer, from Yale University and The Research Foundation of the...

Ritonavir treatment may benefit glioblastoma patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Ritonavir therapy may be beneficial for glioma patients. "Glioblastoma is a therapeutic challenge as a highly infiltrative, proliferative, and resistant tumor," scientists in France explained....

Breast biopsy specimens can be evaluated with proteomic analysis.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers introduce a method of analyzing breast biopsy specimens using proteomic techniques. "Analysis of tumor samples by a proteomic technology, which combines two-dimensional gel...

Breast cancer foundation honors four leaders.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The Susan G. Komen Breast Cancer Foundation honored four leaders in the fight against breast cancer at its annual public policy luncheon on Capitol Hill. The event brought together advocates,...

Breast cancer patients switched to Aromasin more likely to remain cancer free.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Post-menopausal breast cancer patients who switched from tamoxifen to Aromasin (exemestane tablets) had a significantly reduced chance of recurrence and increased disease-free survival compared to...

Caelyx demonstrates efficacy, reduced cardiac toxicity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering-Plough Europe reported that results of a randomized phase III clinical study demonstrated that Caelyx (pegylated liposomal doxorubicin hydrochloride) provided comparable efficacy in the...

Counseling and education can increase anxiety in some breast cancer patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- In general, counseling for women attending a familial breast cancer clinic lessened anxiety and depression and helped them have realistic expectations of the disease. According to a study from...

Epigenetic silencing of adhesion molecule ADAM23 occurs often in breast tumors.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The adhesion molecule A Desintegrin And Metalloprotease domain 23 gene (ADAM 23) may be downregulated during the progression of breast cancer, researchers say. "Altered cell adhesion is causally...

Epirubicin, vinorelbine, and cisplatin are effective in advanced breast cancer.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Combined epirubicin, vinorelbine, and cisplatin resulted in an 84% objective response rate for patients with advanced breast cancer. "Our objective was to evaluate the activity and safety of the...

First large-scale trial of genetically personalized treatment to start soon.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The first large-scale independent trial to study the role of molecular tumor signatures in breast cancer will get underway in the coming year, scientists announced on March 19, 2004, at the 4th European...

Lamivudine helps keep HBV at bay during cancer chemotherapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers in Hong Kong have discovered a way to help prevent the reactivation of the hepatitis B virus (HBV) in women who are being treated with chemotherapy for breast cancer. Winnie Yeo, an...

Letrozole extends time to tumor progression in mouse model.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- In a mouse model of human breast cancer, the drug letrozole more effectively extends time to tumor progression than tamoxifen or various combinations and dosing schedules of tamoxifen plus letrozole....

MEP calls for European strategy in the fight against breast cancer.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The conditions necessary to lead to a 25% reduction in breast cancer mortality must be in place across Europe by 2008, a member of the European Parliament (MEP) said at the opening of the 4th European...

Male carriers of germline mutations in BRCA2 are at increased risk for cancer.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Men with BRCA2 mutations are at greater risk for cancer, especially before age 65, researchers report. "Major risks conferred by BRCA1 and BRCA2 in women are for cancers of the breast, ovary,...